Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind trial of IKH-01 for dysmenorrhea associated with endometriosis
jRCT2080220111Phase 3
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of norethindrone + ethinyl estradiol in dysmenorrhea and endometriosis (2 arms), sponsored by Nobelpharma Co., Ltd.
02
Drugs
norethindrone + ethinyl estradiol
03
Conditions
dysmenorrheaendometriosis
Beyond the preview
Go deeper on jRCT2080220111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220111.